Anaconda Medical

About

Headcount over time

Offices

Q&A

What is Anaconda Medical's primary focus?

Anaconda Medical is a medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke. Their flagship product is the ANA5 Advanced Neurovascular Access™ Thrombectomy Device.

When was Anaconda Medical founded?

Anaconda Medical was founded in 2025.

Where is Anaconda Medical headquartered?

Anaconda Medical is headquartered in Barcelona, Israel.

Who are the co-founders of Anaconda Medical?

The co-founders of Anaconda Medical are Ofir Arad and Marc Ribó, both of whom started in 2015.

Who is the current CEO of Anaconda Medical?

Trent Reutiman was appointed CEO of Anaconda Medical in January 2025.

Who is the Chairman of the Board at Anaconda Medical?

Chuck Carignan became the Board Chairman of Anaconda Medical in June 2025.

How many employees does Anaconda Medical have as of August 2026?

As of August 2026, Anaconda Medical has 23 employees.

Which investors participated in Anaconda Medical's Series A round?

Anaconda Medical raised a Series A round in May 2017 with participation from Ysios Capital.

Which investor led Anaconda Medical's Series B round?

Anaconda Medical closed a Series B round in December 2019, led by Asabys Partners.

Did Anaconda Medical secure any debt financing?

Yes, Anaconda Medical secured $10,000,000 in debt financing in December 2019 from the European Investment Bank.

Team · 9

Ofir Arad

Founder · Co-Founder and Managing Director

Marc Ribó

Founder · Co-Founder

Trent Reutiman

CEO

Hendrik Lambert

CMO

Iñaki Galve

R&D Director

Maria Jose Alonso

Finance Director

Jordi Cardona

Operations Director

Chuck Carignan

Board Chairman

Thomas Harth

Board Member (YSIOS CAPITAL)

Sectors & technology